ENST00000359597.8:c.994-1518T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359597.8(TP53):​c.994-1518T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.875 in 152,210 control chromosomes in the GnomAD database, including 58,506 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.87 ( 58506 hom., cov: 32)

Consequence

TP53
ENST00000359597.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.139

Publications

24 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.944 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000359597.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000359597.8
TSL:1
c.994-1518T>C
intron
N/AENSP00000352610.4
TP53
ENST00000413465.6
TSL:1
c.783-5748T>C
intron
N/AENSP00000410739.2
TP53
ENST00000714356.1
c.984-1518T>C
intron
N/AENSP00000519623.1

Frequencies

GnomAD3 genomes
AF:
0.875
AC:
133032
AN:
152092
Hom.:
58449
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.944
Gnomad AMI
AF:
0.825
Gnomad AMR
AF:
0.900
Gnomad ASJ
AF:
0.813
Gnomad EAS
AF:
0.966
Gnomad SAS
AF:
0.722
Gnomad FIN
AF:
0.846
Gnomad MID
AF:
0.669
Gnomad NFE
AF:
0.841
Gnomad OTH
AF:
0.853
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.875
AC:
133145
AN:
152210
Hom.:
58506
Cov.:
32
AF XY:
0.873
AC XY:
64985
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.944
AC:
39211
AN:
41554
American (AMR)
AF:
0.900
AC:
13759
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.813
AC:
2821
AN:
3470
East Asian (EAS)
AF:
0.966
AC:
4979
AN:
5154
South Asian (SAS)
AF:
0.722
AC:
3482
AN:
4826
European-Finnish (FIN)
AF:
0.846
AC:
8977
AN:
10612
Middle Eastern (MID)
AF:
0.661
AC:
193
AN:
292
European-Non Finnish (NFE)
AF:
0.841
AC:
57167
AN:
67996
Other (OTH)
AF:
0.854
AC:
1804
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
854
1709
2563
3418
4272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.858
Hom.:
16624
Bravo
AF:
0.885
Asia WGS
AF:
0.879
AC:
3057
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
5.3
DANN
Benign
0.74
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9894946; hg19: chr17-7571080; API